A high performance liquid chromatography method for the quantitative determination of erlotinib in the plasma of tumor bearing BALB/c nude mice and its application in a pharmacokinetic study

李汉青,陈烨,李载权,邓晨辉,李良,毕姗姗,李梦瑶,周田彦,卢炜
DOI: https://doi.org/10.5246/jcps.2011.03.030
2011-01-01
Abstract:A new HPLC-UV method was developed and validated for the quantitative determination of epidermal growth factor receptor inhibitor erlotinib in the plasma of tumor bearing BALB/c nude mice.Erlotinib and its internal standard l-(3-((6,7-bis(2- methoxyethoxy)quinazolin-4-yl)amino)phenyl)ethanone were extracted from mice plasma samples using liquid-liquid extraction with a mixed solvent of methyl t-butyl ether and ethyl acetate(9:1,v/v).Chromatographic separation was performed on a Luna C|_(18)column(4.6 mm×250 mm,5μm)with acetonitrile:5 mM potassium phosphate buffer pH=5.2(41:59,v/v)as the mobile phase.UV detector was set at the wavelength of 345 nm,and the flow rate was 1.0 mL/min.The calibration curve was linear over the range of 20-10 000 ng/mL with acceptable intra-and inter-day precision and accuracy.The intra-day and inter-day precisions were within the range of 1.69%—5.66%,and the accuracies of intra-and inter-day assays were within the range of 105%—113%. The mean recoveries were 85.2%and 96.1%for erlotinib and IS,respectively.This method was successfully applied to a pharmacokinetic study in tumor bearing BALB/c nude mice following single oral administration at the dose of 12.5 mg/kg. The main pharmacokinetic parameters were as follows:C_(max)was 4.67μg/mL,T_(max)was 1.0 h,T_(1/2)was 2.78 h,and AUC_(0-24h)was 18.0μg/mL·h.
What problem does this paper attempt to address?